Epitomee Medical Ltd (EPIT) — Defensive Interval Ratio
Epitomee Medical Ltd (EPIT) has a Defensive Interval Ratio of 60 days as of June 2025. Defensive assets of ILA402.57K (cash ILA-, short-term investments ILA87.57K, receivables ILA315.00K) cover 60 days of daily cash needs of ILA6.68K/day. See EPIT working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Epitomee Medical Ltd Defensive Interval Ratio (2020–2024)
This chart shows how Epitomee Medical Ltd's Defensive Interval Ratio has evolved across 5 annual periods from 2020 to 2024. As of June 2025, the ratio stands at 60 days, meaning defensive assets of ILA402.57K can fund 60 days of operations without new revenue. See net asset quality index of Epitomee Medical Ltd to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Epitomee Medical Ltd (2020–2024)
The table below presents the year-by-year Defensive Interval Ratio for Epitomee Medical Ltd from 2020 to 2024, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Epitomee Medical Ltd.
| Year | DIR (days) | Defensive Assets (ILA) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 2958 days | ILA20.25 Million | ILA6.85K/day | ILA- | ILA20.04 Million | ▼ -10079 days |
| 2023 | 13037 days | ILA69.86 Million | ILA5.36K/day | ILA- | ILA69.24 Million | ▲ +6885 days |
| 2022 | 6152 days | ILA36.42 Million | ILA5.92K/day | ILA- | ILA35.78 Million | ▲ +5972 days |
| 2021 | 180 days | ILA1.21 Million | ILA6.70K/day | ILA- | ILA- | ▼ -23689 days |
| 2020 | 23870 days | ILA50.36 Million | ILA2.11K/day | ILA- | ILA50.09 Million | — |